Arcadia Biosciences (RKDA) Short-term Investments (2015 - 2025)

Arcadia Biosciences has reported Short-term Investments for 10 years, with the latest figure at $4.3 million in Q4 2025.

• For the quarter ending Q4 2025, Short-term Investments changed N/A year-over-year to $4.3 million; the trailing twelve-month figure through Dec 2025 stood at $4.3 million (changed N/A YoY), and the FY2025 full-year result was $4.3 million, changed N/A from the prior year.
• Short-term Investments for Q4 2025 stood at $4.3 million, down from $4.8 million in the prior quarter.
• The five-year high for Short-term Investments was $19.1 million in Q1 2021, with the low at $2.6 million in Q2 2024.
• Historically, Short-term Investments has averaged $5.7 million across 4 years, with a median of $4.9 million in 2023.
• Annual changes were most pronounced in 2021 — Short-term Investments soared 526.86% — and 2024, when it slumped 49.02%.
• Arcadia Biosciences' Short-term Investments stood at $19.1 million in 2021, then plunged by 73.16% to $5.1 million in 2023, then sank by 49.26% to $2.6 million in 2024, then jumped by 65.54% to $4.3 million in 2025.
• The last three Short-term Investments figures came in at $4.3 million (Q4 2025), $4.8 million (Q3 2025), and $3.1 million (Q2 2025), per Business Quant data.